BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 8956803)

  • 1. Mammographic screening after the age of 65 years: early outcomes in the Nijmegen programme.
    van Dijck J; Verbeek A; Hendriks J; Holland R; Mravunac M
    Br J Cancer; 1996 Dec; 74(11):1838-42. PubMed ID: 8956803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Age-specific effectiveness of the Nijmegen population-based breast cancer-screening program: assessment of early indicators of screening effectiveness.
    Peer PG; Holland R; Hendriks JH; Mravunac M; Verbeek AL
    J Natl Cancer Inst; 1994 Mar; 86(6):436-41. PubMed ID: 8120918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of changing from annual to biennial mammographic screening on breast cancer outcomes in women aged 50-79 in British Columbia.
    Coldman AJ; Phillips N; Olivotto IA; Gordon P; Warren L; Kan L
    J Med Screen; 2008; 15(4):182-7. PubMed ID: 19106258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of mammographic breast density on breast cancer screening performance: a study in Nijmegen, The Netherlands.
    van Gils CH; Otten JD; Verbeek AL; Hendriks JH; Holland R
    J Epidemiol Community Health; 1998 Apr; 52(4):267-71. PubMed ID: 9616416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long term breast cancer screening in Nijmegen, The Netherlands: the nine rounds from 1975-92.
    Otten JD; van Dijck JA; Peer PG; Straatman H; Verbeek AL; Mravunac M; Hendriks JH; Holland R
    J Epidemiol Community Health; 1996 Jun; 50(3):353-8. PubMed ID: 8935470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of mammographic screening of the elderly: a case-referent study in the Nijmegen program in The Netherlands.
    van Dijck JA; Holland R; Verbeek AL; Hendriks JH; Mravunac M
    J Natl Cancer Inst; 1994 Jun; 86(12):934-8. PubMed ID: 8196083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The National Breast and Cervical Cancer Early Detection Program: report on the first 4 years of mammography provided to medically underserved women.
    May DS; Lee NC; Nadel MR; Henson RM; Miller DS
    AJR Am J Roentgenol; 1998 Jan; 170(1):97-104. PubMed ID: 9423608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breast cancer survival rates with mammographic screening: similar favorable survival rates for women younger and those older than 50 years.
    Thurfjell EL; Lindgren JA
    Radiology; 1996 Nov; 201(2):421-6. PubMed ID: 8888234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening for breast cancer in Nijmegen. Report of 6 screening rounds, 1975-1986.
    Peeters PH; Verbeek AL; Hendriks JH; van Bon MJ
    Int J Cancer; 1989 Feb; 43(2):226-30. PubMed ID: 2917799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breast-cancer mortality in a non-randomized trial on mammographic screening in women over age 65.
    Van Dijck JA; Verbeek AL; Beex LV; Hendriks JH; Holland R; Mravunac M; Straatman H; Werre JM
    Int J Cancer; 1997 Jan; 70(2):164-8. PubMed ID: 9009155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mammography screening in the county of Fyn. November 1993-December 1999.
    Njor SH; Olsen AH; Bellstrøm T; Dyreborg U; Bak M; Axelsson C; Graversen HP; Schwartz W; Lynge E
    APMIS Suppl; 2003; (110):1-33. PubMed ID: 12739252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ten years of breast screening in the Screening Mammography Program of British Columbia, 1988-97.
    Olivotto IA; Kan L; d'Yachkova Y; Burhenne LJ; Hayes M; Hislop TG; Worth AJ; Basco VE; King S
    J Med Screen; 2000; 7(3):152-9. PubMed ID: 11126165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mammographic screening after the age of 65 years: evidence for a reduction in breast cancer mortality.
    Van Dijck JA; Verbeek AL; Beex LV; Hendriks JH; Holland R; Mravunac M; Straatman H; Werre JM
    Int J Cancer; 1996 Jun; 66(6):727-31. PubMed ID: 8647640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effective biennial mammographic screening in women aged 40-49.
    van Schoor G; Moss SM; Otten JD; Donders R; Paap E; den Heeten GJ; Holland R; Broeders MJ; Verbeek AL
    Eur J Cancer; 2010 Dec; 46(18):3137-40. PubMed ID: 21036034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breast cancer screening by mammography in women aged under 50 years in Japan.
    Morimoto T; Sasa M; Yamaguchi T; Kondo H; Akaiwa H; Sagara Y
    Anticancer Res; 2000; 20(5C):3689-94. PubMed ID: 11268440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relative effect of mammographic screening on breast cancer mortality by socioeconomic status.
    Ripping TM; van der Waal D; Verbeek ALM; Broeders MJM
    Medicine (Baltimore); 2016 Aug; 95(31):e4335. PubMed ID: 27495038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Positive predictive value of screening mammography by age and family history of breast cancer.
    Kerlikowske K; Grady D; Barclay J; Sickles EA; Eaton A; Ernster V
    JAMA; 1993 Nov; 270(20):2444-50. PubMed ID: 8230621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect on breast cancer mortality of biennial mammographic screening of women under age 50.
    Peer PG; Werre JM; Mravunac M; Hendriks JH; Holland R; Verbeek AL
    Int J Cancer; 1995 Mar; 60(6):808-11. PubMed ID: 7896450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening interval breast cancers: mammographic features and prognosis factors.
    Burrell HC; Sibbering DM; Wilson AR; Pinder SE; Evans AJ; Yeoman LJ; Elston CW; Ellis IO; Blamey RW; Robertson JF
    Radiology; 1996 Jun; 199(3):811-7. PubMed ID: 8638010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The comparative value of mammographic screening for women 40-49 years old versus women 50-64 years old.
    Curpen BN; Sickles EA; Sollitto RA; Ominsky SH; Galvin HB; Frankel SD
    AJR Am J Roentgenol; 1995 May; 164(5):1099-103. PubMed ID: 7717212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.